Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole in Idiopathic Restless Legs Syndrome
NCT00349531Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 4, randomised, double-blind trial in restless legs syndrome (RLS) comparing Pramipexole with Placebo (2 arms). Primary endpoints: International Restless Legs Syndrome Study Group Rating Scale total score at 12 weeks and Medical Outcomes Study sleep disturbance score at 12 weeks. Started Jul 2006; status: completed.
02
Drugs
pramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00349531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349531.